SCHEMBL16767804

SCHEMBL16767804

Cc1c(B2OC(C)(C)C(C)(C)O2)sc(B2OC(C)(C)C(C)(C)O2)c1C

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LPL P06858 5/20 0.33
LIPG Q9Y5X9 5/20 0.33
P2RX7 Q99572 1/20 0.33
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15532387 0.89 LPL (0.31) LPLLIPGP2RX7
SCHEMBL18558771 0.82
SCHEMBL13868373 0.80 ESR2 (0.32)
SCHEMBL13868372 0.73 ESR2 (0.31)
SCHEMBL594378 0.73 LPL (0.39) LPLLIPG
SCHEMBL14865876 0.73
SCHEMBL16389649 0.73 MAPK1 (0.35) P2RX7MAPK1
SCHEMBL14846427 0.72
SCHEMBL18133779 0.72 LPL (0.35) LPLLIPGP2RX7MAPK1
SCHEMBL16373588 0.72 LPL (0.32) LPLLIPGP2RX7MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9969931-B2 Electrochromic composition and electrochromic element CANON KABUSHIKI KAISHA (JP) 2018-05-15 US disclosed
US-9969931-B2 Electrochromic composition and electrochromic element CANON KABUSHIKI KAISHA (JP) 2018-05-15 US disclosed
US-20170114274-A1 ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT CANON KABUSHIKI KAISHA (JP) 2017-04-27 US disclosed
US-20170114274-A1 ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT CANON KABUSHIKI KAISHA (JP) 2017-04-27 US disclosed
US-9310660-B2 Organic compound and electrochromic element including the same CANON KABUSHIKI KAISHA (JP) 2016-04-12 US disclosed
US-9310660-B2 Organic compound and electrochromic element including the same CANON KABUSHIKI KAISHA (JP) 2016-04-12 US disclosed
WO-2016006204-A1 ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT CANON KABUSHIKI KAISHA (JP) 2016-01-14 WO disclosed
US-20150153624-A1 NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2015-06-04 US disclosed
US-20150153624-A1 NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2015-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170114274-A1 ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT SCN11A, ECH1, H1-0 LPL 4773/4885LIPG 4342/4885P2RX7 1562/4885
US-20150153624-A1 NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT INCLUDING THE SAME ETV6, H1-0, HCN2 LPL 4482/4885LIPG 4200/4885P2RX7 3321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.